News
The US has cancelled $500 million in mRNA vaccine funding, impacting 22 projects by Pfizer, Moderna, and others, citing ...
US FDA accepts for priority review Bristol Myers Squibb’s sBLA for Breyanzi to treat adult patients with relapsed or refractory MZL: Princeton, New Jersey Wednesday, August 6, 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results